Concord Biotech Limited
ListedMainboardPharmaceuticals & Biotechnology · NSE / BSE
Incorporated in 1984, Concord Biotech Limited is an India-based biopharmaceutical company and a leading global developer and manufacturer of fermentation-based APIs, specializing in immunosuppressants and oncology. The company has a strong global presence, supplying products to over 70 countries including the USA, India, Europe, and Japan. Concord Biotech manufactures Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, along with finished formulations. Starting with a single product, the company has expanded to offer a broad spectrum of biopharma solutions, establishing itself as a key player in the global API market.
Price Band
₹705 – ₹741
Issue Size
₹1551 Cr
Lot Size
20 shares
GMP
₹125
+16.9%
Est. Listing
₹866
at current GMP
Subscribed
26.13x
overall
Open
4 Aug 2023
Close
8 Aug 2023
Allotment
14 Aug 2023
Refund
15 Aug 2023
Demat Credit
16 Aug 2023
Listing
18 Aug 2023
Last updated 12 days ago
Key Highlights
- •Leading player in the Pharmaceuticals & Biotechnology segment
- •Price band established at ₹705 - ₹741 per equity share
- •Minimum bid lot is 20 shares
- •Estimated listing target of ₹866 based on current grey market activity